HealthQuill Articles by: HealthQuill
Microbiologists at Northwestern University have found toothbrushes and showerheads were teeming with diverse viruses not seen so far — and they don’t target humans, but bacteria.
Drugs Health Pharma

`Toothbrushes, showerheads nurture human-friendly bacteria’

Microbiologists at Northwestern University have found toothbrushes and showerheads were teeming with diverse viruses not seen so far — and they don’t target

Read More
Pfizer Inc., got a nod from the US drug regulator for its drug Hympavzi to treat two types of a rare blood disorder in haemophilia patients.
Drugs Health Pharma

Pfizer’s drug to treat rare haemophilia disorder gets US regulator’s approval

Pfizer Inc., got a nod from the US drug regulator for its drug Hympavzi to treat two types of a rare blood disorder

Read More
Vaccines against 24 pathogens could cut the number of antibiotics needed to fight antimicrobial resistance by 2.5 billion daily doses or 22% globally, according to a World Health Organization report.
Drugs Health Pharma

Vaccines against pathogens can cut global antibiotic usage by 22%

Vaccines against 24 pathogens could cut the number of antibiotics needed to fight antimicrobial resistance by 2.5 billion daily doses or 22% globally,

Read More
Drugs Health Pharma

Skin care products with benzoyl peroxide can turn carcinogenic

HQ Team October 10, 2024: A recent study has raised concerns about the safety of topical benzoyl peroxide (BPO) products used for treating

Read More
Granules India announced the US Food & Drug Administration (US FDA) had approved an Abbreviated New Drug Application (ANDA) for losartan potassium tablets to treat high blood pressure.
Drugs Health Pharma

Researchers find new tech to change IV therapies into oral pills

HQ Team October 10, 2024: A study published in Nature Communications discusses a novel water-soluble prodrug technology called Sol-moiety, which enhances the oral bioavailability of

Read More
US-based Baxter International Inc., is implementing an allocation policy to limit stockpiling of its drugs after Hurricane Helene ripped through its facility in North Carolina.
Climate Drugs Medical

Baxter plans to limit stockpiling of its drugs after Hurricane Helene

US-based Baxter International Inc., is implementing an allocation policy to limit stockpiling of its drugs after Hurricane Helene ripped through its facility in

Read More
As Hurricane Milton looms large over the Florida coast, weather climate researchers said rainfall caused by Hurricane Helene, which struck two weeks before, was amplified by about 10% and its winds by 11% due to climate change.
Climate Health Pharma

Climate change amplified US Hurricane Helene’s rainfall, winds

As Hurricane Milton looms large over the Florida coast, weather climate researchers said rainfall caused by Hurricane Helene, which struck two weeks before,

Read More
Dengue cases in the Americas Region exceeded the number of cases historically reported in a year, as compared to all previously recorded years, according to the Pan American Health Organization.
Health Medical Pharma

Dengue cases at an all-time high in Americas Region: PAHO report

Dengue cases in the Americas Region exceeded the number of cases historically reported in a year, as compared to all previously recorded years,

Read More
GSK Plc.’s single dose respiratory syncytial virus (RSV) vaccine for a severe form of the disease proved 43.3% effective in the third season compared to 94.1% in the first and 64.2% in the second.
Drugs Health Pharma

GSK’s vaccine for severe RSV shows 43.3% effectiveness in third year

GSK Plc.’s single dose respiratory syncytial virus (RSV) vaccine for a severe form of the disease proved 43.3% effective in the third season

Read More
Sage Therapeutics Inc.’s experimental drug failed to meet its main goal of treating mild dementia due to Alzheimer's disease and the US, Cambridge-headquartered company has halted its trials.
Drugs Health Pharma

Sage Therapeutics halts trials of experimental drug to treat dementia

Sage Therapeutics Inc.’s experimental drug failed to meet its main goal of treating mild dementia due to Alzheimer's disease and the US, Cambridge-headquartered

Read More